期刊文献+

脑肿瘤的^(31)PMRS特征

^(31)P MRS characteristics of cerebral tumors in vivo
下载PDF
导出
摘要 目的比较不同脑肿瘤31PMRS的变化特征,探讨31PMRS在脑肿瘤中的临床应用价值。方法正常组36例,Ⅱ~Ⅲ级胶质瘤16例,成胶质细胞瘤12例,脑膜瘤16例。在1.5TMR机上完成波谱采集,jMRUI(1.3版)软件分析数据,计算体素内的pH值和各代谢物与β-ATP的相对浓度。结果正常组pH7.04±0.02,PCr/β-ATP1.51±0.03,PCr/Pi2.85±0.20,PDE/β-ATP2.70±0.40,PME/β-ATP1.01±0.03。Ⅱ~Ⅲ级胶质瘤组织碱性化,pH7.09±0.01,与正常组比较P<0.05;PCr/β-ATP(1.50±0.04)、PCr/Pi(2.49±0.21)、PME/β-ATP(1.04±0.07)与正常组比较无显著性差异;PDE/β-ATP(1.73±0.20)显著降低,P<0.05。成胶质细胞瘤组织碱性化,pH7.12±0.02,与正常组比较P<0.05;PCr/β-ATP(1.48±0.05)、PCr/Pi(2.39±0.23)与正常组比较无显著性差异;PDE/β-ATP(1.61±0.25)显著降低,P<0.05;PME/β-ATP(1.64±0.05)显著升高,P<0.05。脑膜瘤组织学特征是碱性化,pH7.16±0.03,与正常组比较P<0.005;PCr和PDE显著降低,PCr/β-ATP(0.46±0.04,P<0.001)、PCr/Pi(1.08±0.16,P<0.001)、PDE/β-ATP(0.82±0.10,P<0.001)显著降低,PME/β-ATP(2.05±0.03,P<0.005)显著升高。结论不同脑肿瘤在活体31PMRS上的变化具有特征性;31PMRS能无创性提供活体脑肿瘤pH值、能量状况及其磷脂代谢等方面的信息,有利于脑肿瘤的诊断与鉴别诊断。 Objective To analyze feature of various cerebral tumors on 31 p MRS and to explore the clinical application of 31PMRS in cerebral neoplasm. Methods The total subjects included control group (n= 36), Ⅱ-Ⅲ grade gliomas (n= 16), glioblastomas (n= 12) and meningiomas (n= 16). All data were obtained by 1.5T MR scanner, the data were analyzed with jMRUI (1.3) software, and their pH value and semi quantitive metabolites divided by β-ATP were calculated. Results Control group: pH (7.04±0.02), PCr/β-ATP (1.51±0. 03), PCr/Pi (2.85±0.20), PDE/β-ATP (2.70±0.40), PME/β-ATP (1.01±0.03). Ⅱ-Ⅲ grade gliomas: alkalosis (pH 7.09±0.01, P〈0.05), PCr/β-ATP (1.50±0.04), PCr/Pi (2.49 ± 0.21 ) ; To compare with control group, PDE/β-ATP ( 1.73 ± 0.20), P〈0.05. Glioblastomas: far more alkalosis, pH 7.12±0.02, P〈0.05; PCr/β-ATP (1.48±0. 05), PCr/Pi (2.39±0.23), PDE/β-ATP (1.61±0.25), P〈0.05, sig- nificantly decreased; PME/β-ATP (1.64±0.05, P〈0.05), significantly increased. Meningiomas: obvious alkalosis, pH 7.16±0.03, P〈0. 005; PCr and PDE significantly decreased, PCr/β-ATP (0.46±0.04, P〈0. 001); PCr/Pi (1.08± 0.16, P〈 0. 001) ; PDE/β-ATP significantly decreased, (0. 82 ± 0. 10, P〈 0. 001) ; PME/β-ATP increased significantly (2.05±0.03, P〈0. 005). Conclusion Different cerebral neoplasms demonstrate characteristic change of ^31P MRS. ^31P MRS is capable of providing information about cerebral tumor pH, metabolism of energy and phospholipid. It is helpful for diagnosis and differential diagnosis of brain tumor.
出处 《中国医学影像技术》 CSCD 北大核心 2006年第4期518-520,共3页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金资助项目(30400136) 湖北省卫生厅资助课题(301140319)。
关键词 脑肿瘤 磁共振波谱学 磷脂代谢 活体 Brain neoplasms, Magnetic resonance spectroscopy Phospholipid metabolism In vivo
  • 相关文献

参考文献11

  • 1Griffiths JR,Cady E,Edwards RH,et al.31P-NMR studies of a human tumour in situ[J].Lancet,1983,1(8339):1435-1436.
  • 2Podo F.Tumour phospholipid metabolism[J].NMR Biomed,1999,12(7):413-439.
  • 3Albers MJ,Krieger MD,Gonzalez-Gomez I,et al.Proton-decoupled 31P MRS in untreated pediatric brain tumors[J].Magn Reson Med,2005,53(1):22-29.
  • 4Jensen JE,Drost DJ,Menon RS,et al.In vivo brain (31)P-MRS:measuring the phospholipid resonances at 4 Tesla from small voxels[J].NMR Biomed,2002,15(5):338-347.
  • 5Govindaraju V,Young K,Maudsley AA.Proton NMR chemical shifts and coupling constants for brain metabolites[J].NMR Biomed,2000,13(3):129-153.
  • 6Negendank WG,Sauter R,Brown TR,et al.Proton magnetic resonance spectroscopy in patients with glial tumors:a multicenter study[J].J Neurosurg,1996,84(3):449-458.
  • 7Howe FA,Opstad KS.1H MR spectroscopy of brain tumors and masses[J].NMR Biomed,2003,16(3):123-131.
  • 8吴光耀,雷皓,孙骏谟,田志雄,黄雄.脑内环状强化病变质子磁共振波谱研究[J].中国医学影像技术,2005,21(4):526-529. 被引量:13
  • 9Mahon MM,Cox IJ,Dina R,et al.1H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer:in vivo-ex vivo profiles and effect of tumor load[J].J Magn Reson Imaging,2004,19(3):356-364.
  • 10Kinoshita Y,Yokota A.Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy[J].NMR Biomed,1997,10(1):2-12.

二级参考文献12

  • 1Poptani H, Gupta RK, Jain VK, et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis[J].Magn Reson Imaging,1995,13(7):1019-1029.
  • 2Shukla-Davea A, Guptaa RK, Royd R, et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions[J]. Magn Reson Imaging,2001,19(1):103-110.
  • 3Kamada K, Houkin K, Abe H, et al. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy[J]. Neurol Med Chir, 1997, 37(2): 250-256.
  • 4Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance[J]. Radiology, 1992, 185(3): 675-686.
  • 5David KW, Yu-leung C, Sing-fai L, et al. Detection of an intense resonance at 2.4 ppm in 1H MR pectra of patients with severe late-delayed, radiation-induced brain injuries[J]. Magn Reson Med,2001,45(5):994-1000.
  • 6Podo F. Tumour phospholipid metabolism[J].NMR Biomed,1999,12(5): 413-439.
  • 7Sudhakar KV, Rakesh KG, Lily P, et al. Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain[J]. J Magn Reson Imaging,2001,14(1): 8-15.
  • 8Sylvie G, Ghislaine P, Anne Z, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy-initial results[J].Radiology,1999,213(3):785-793.
  • 9Monika G, Rakesh KG, Mazhar H, et al. Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy[J]. Radiology,2004,230(2):519-527.
  • 10Akutsu H, Matsumura A, Isobe T, et al. Chronological change of brain abscess in 1H magnetic resonance spectroscopy[J].Neuroradiology,2002,44(2):574-578.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部